To reduce pill burden of COVID-19 treatment, Glenmark introduces higher strength of FabiFlu
NE BUSINESS BUREAU MUMBAI, AUG 6 Drug firm Glenmark Pharmaceuticals on Thursday said it will launch a 400 mg version ...
Tag: mild and moderate COVID-19
